JP2019527724A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019527724A5 JP2019527724A5 JP2019508251A JP2019508251A JP2019527724A5 JP 2019527724 A5 JP2019527724 A5 JP 2019527724A5 JP 2019508251 A JP2019508251 A JP 2019508251A JP 2019508251 A JP2019508251 A JP 2019508251A JP 2019527724 A5 JP2019527724 A5 JP 2019527724A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkenyl
- linear
- branched alkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1613942.0A GB201613942D0 (en) | 2016-08-15 | 2016-08-15 | An antimicrobial compound |
| GB1613942.0 | 2016-08-15 | ||
| PCT/GB2017/052393 WO2018033714A1 (en) | 2016-08-15 | 2017-08-15 | An antimicrobial compound |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019527724A JP2019527724A (ja) | 2019-10-03 |
| JP2019527724A5 true JP2019527724A5 (enExample) | 2020-09-24 |
| JP7060579B2 JP7060579B2 (ja) | 2022-04-26 |
Family
ID=56985954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508251A Expired - Fee Related JP7060579B2 (ja) | 2016-08-15 | 2017-08-15 | 抗微生物化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11247973B2 (enExample) |
| EP (1) | EP3497096B1 (enExample) |
| JP (1) | JP7060579B2 (enExample) |
| GB (1) | GB201613942D0 (enExample) |
| WO (1) | WO2018033714A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201911944D0 (en) | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
| GB201915273D0 (en) | 2019-10-22 | 2019-12-04 | Reviral Ltd | Pharmaceutical compounds |
| GB201915932D0 (en) | 2019-11-01 | 2019-12-18 | Reviral Ltd | Pharmaceutical compounds |
| GB202010409D0 (en) | 2020-07-07 | 2020-08-19 | Reviral Ltd | Pharmaceutical compounds |
| GB202010408D0 (en) | 2020-07-07 | 2020-08-19 | Reviral Ltd | Pharmaceutical compounds |
| GB202102602D0 (en) | 2021-02-24 | 2021-04-07 | Reviral Ltd | Pharmaceutical compounds |
| WO2024252355A1 (en) | 2023-06-08 | 2024-12-12 | Pfizer Inc. | Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv |
| WO2025120500A1 (en) | 2023-12-06 | 2025-06-12 | Pfizer Inc. | Benzodiazepine compounds as n-protein inhibitors |
| WO2025153942A1 (en) | 2024-01-16 | 2025-07-24 | Pfizer Inc. | Benzodiazepine pyrazolo carboxamides as n-protein inhibitors |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5004741A (en) * | 1984-06-26 | 1991-04-02 | Merck & Co., Inc. | Methods of antagonizing CCK or gastrin with benzodiazepine analogs |
| US4820834A (en) | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
| US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| US5426185A (en) * | 1993-11-22 | 1995-06-20 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
| AU3400797A (en) * | 1996-06-27 | 1998-01-14 | Merck & Co., Inc. | A method for treating meniere's disease |
| CA2257948A1 (en) | 1996-06-28 | 1998-01-08 | Merck & Co., Inc. | Antiarrhythmic combinations of selective iks antagonists with beta-adenergic blocking agents |
| US5776930A (en) * | 1996-06-28 | 1998-07-07 | Merck & Company, Inc. | Pharmaceutical preparation |
| US5817658A (en) * | 1997-03-14 | 1998-10-06 | Merck & Company, Inc. | Method for treating Meniere's disease |
| WO2000012547A2 (en) * | 1998-09-01 | 2000-03-09 | Innogenetics N.V. | Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use |
| MXPA05002871A (es) | 2002-09-20 | 2005-10-05 | Arrow Therapeutics Ltd | Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen. |
| GB0406280D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Chemical compounds |
| WO2005090319A1 (en) | 2004-03-19 | 2005-09-29 | Arrow Therapeutics Limited | Process for preparing benzodiazepines |
| GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| GB0406279D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| AU2005336627A1 (en) * | 2005-09-19 | 2007-03-29 | Arrow Therapeutics Limited | Benzodiazepine derivatives for treating hepatitis C infection |
| MX2009005368A (es) | 2006-11-21 | 2009-06-05 | Novartis Ag | Formulacion parenteral estable que contiene un inhibidor de rsv de una estructura de benzodiazepina. |
| WO2011151651A1 (en) * | 2010-06-03 | 2011-12-08 | Arrow Therapeutics Limited | Benzodiazepine compounds useful for the treatment of hepatitis c |
| WO2011151652A1 (en) * | 2010-06-03 | 2011-12-08 | Arrow Therapeutics Limited | Benzodiazepine compounds useful for the treatment of hepatitis c |
| GB201506448D0 (en) * | 2015-04-16 | 2015-06-03 | Univ Durham | An antimicrobial compound |
| AU2016297024B2 (en) * | 2015-07-22 | 2021-03-04 | Enanta Pharmaceuticals, Inc. | Benzodiazepine derivatives as RSV inhibitors |
| GB201911944D0 (en) * | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
-
2016
- 2016-08-15 GB GBGB1613942.0A patent/GB201613942D0/en not_active Ceased
-
2017
- 2017-08-15 US US16/323,496 patent/US11247973B2/en not_active Expired - Fee Related
- 2017-08-15 EP EP17754472.3A patent/EP3497096B1/en not_active Not-in-force
- 2017-08-15 WO PCT/GB2017/052393 patent/WO2018033714A1/en not_active Ceased
- 2017-08-15 JP JP2019508251A patent/JP7060579B2/ja not_active Expired - Fee Related